Treatment of CRC cell lines with curcumin which inhibits NFκB signalling potentiated the response to 5-FU and when tested in combination with RT in CRC xenografts a reduction in tumour growth was observed (Refs 46, 47). The gene discussed is NFKB1; the disease is neoplasm.